Thomas Bradshaw

Company: Neuronasal

Job title: Chief Executive Officer

Seminars:

Aligning Device-Formulation Compatibility for CNS Indications 10:00 am

Delving into cutting-edge unique method of tracking brain delivery using magnetic resonance spectroscopy for confidence in delivery accuracy Leveraging devices to gain access to the CNS for multiple indications across Parkinson’s, Concussion, MS, and Stroke for optimized patient experience Gaining highly efficient nose-to-brain delivery bypassing the blood brain barrier with specialized formulations and intranasal devicesRead more

day: Conference Day Two